HOTH

Hoth Therapeutics Inc. (HOTH) | Rumor.io

Hoth Therapeutics

HOTH

Attention (50-day avg)0%

Attention rank (50-day avg)#4,850

Bullish sentiment (50-day avg)100%

Price to earnings ratio-0.82

Market capitalization14.1M

Earnings per share-0.8

Dividend yield (TTM)—

Revenue (annual)0

Net income (annual)-12.5M

Social

What share of all stock conversation is about HOTH?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Attention	0% new	0% new	0% 0	0% 0

May 28

Hoth Therapeutics (now known as Rocket One Inc.) has rebranded to focus on nanomagnetic AI chip technology for space and defense applications.
The company's stock has seen significant price increases, with a 92% gain on May 28, 2026, following the rebrand and ticker change from HOTH to RKTO.
Hoth Therapeutics' business has shifted from its original focus on healthcare and medical research to a new direction in AI computing and semiconductor technologies.

Generated by AI

Sentiment

Of the messages about HOTH that take a side, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Bullish	—	—	—	94.53% +0.71
Bearish	—	—	—	5.47% -0.71

Bullish· May 28

$HOTH has shown significant price appreciation, with a 600% increase, making it a promising investment opportunity.
The company's stock has demonstrated strong momentum, with a 97.8% intraday rise and a subsequent increase in price to $1.36.
The asset's rebranding as $RKTO has been successful, with a 300% increase in value since the announcement, indicating a strong and sustainable trend.

Bearish· May 28

Hoth Therapeutics' market capitalization is too small to compete with trillion-dollar TAM sectors in AI, space, and defense.
The company's focus on radiation-tolerant AI chips, edge AI for satellites, and ultra-low-power computing may not be enough to capture significant market share in these growing sectors.
Hoth Therapeutics is targeting large and growing markets, but its valuation remains at a microcap level, potentially limiting its ability to attract investment and achieve its goals.

Generated by AI

Topics

Of the messages about HOTH that carry a topic, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y
Analysts	—	—	—	1.65%
Announcements	—	—	—	69.09%
Controversies	—	—	—	1.1%
Earnings	—	—	—	0%
Macro	—	—	—	2.88%
Technical Analysis	—	—	—	25.27%

May 27

Hoth Therapeutics, Inc. has rebranded as Rocket One Inc. with a new ticker symbol $RKTO, marking a strategic pivot from biotech to the space economy.
The company has secured exclusive rights to nanomagnetic AI chip technology and ultra-low-power, radiation-tolerant computing for space and defense applications.
Hoth Therapeutics' shares have rallied significantly, with a 92% increase in stock price, following the announcement of its transformation into Rocket One and its entry into the space economy.

Generated by AI

Community

Of the messages about HOTH, what share comes from each group?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Regulars	0%	0%	0%	31.98%
Newcomers	100%	100%	100%	68.02%

Regulars· May 27

The company has completed a name change to Rocket One Inc. and will begin trading as RKTO on the Nasdaq on May 28, 2026, with legacy biotechnology programs continuing under a wholly owned subsidiary.
Rocket One holds exclusive rights to nanomagnetic AI chip technology, targeting the space economy with next-generation nanomagnetic AI chip technology and ultra-low-power, radiation-tolerant computing for space and defense applications.
The stock has seen a massive rally in response to the name change, with some participants expecting a break and base over highs, while others are covering shorts before the change takes effect.

Newcomers· May 28

Many newcomers are celebrating the 600% and 400% gains on $HOTH, with some reporting realized profits of almost 7k.
Some users are questioning the validity of the stock's performance, with one user suggesting it's a scam and another asking where their "HOTH peeps" are.
Newcomers are discussing the company's rebrand to Rocket One Inc. and its focus on orbital computing and defense tech, with one user highlighting the company's new cash runway and warrants overhead.

Generated by AI

Also Discussed

Investors talking about HOTH also mention

#	Name	Attention
1	JFBR - Jeffs' Brands Ltd	——
2	SciSparc Ltd.SPRC	0%+0
3	Silo Pharma Inc.SILO	0%new
4	Lixte Biotechnology Holdings Inc.LIXT	0%new
5	FRTX - Fresh Tracks Therapeutics, Inc.	——
6	Dermata Therapeutics, Inc.DRMA	0%new
7	TFFP - TFF Pharmaceuticals, Inc.	——
8	VCNX - Vaccinex, Inc.	——
9	THMO - ThermoGenesis Holdings, Inc.	——
10	Adial Pharmaceuticals, Inc.ADIL	0%0

Hoth Therapeutics Inc.

Healthcare
Biotechnology

Hoth Therapeutics Inc. is a clinical-stage biopharmaceutical company focused on developing innovative therapies for dermatological disorders, infectious diseases, and oncology. Its lead candidate, HT-001, is a topical therapeutic designed to treat chemotherapy-induced rash, enabling patients to continue their cancer treatments without painful side effects, and is currently advancing through Phase 2 trials. The company is also developing HT-KIT, an oncology drug targeting cancer treatments, alongside initiatives in obesity in partnership with the U.S. Department of Veterans Affairs. Hoth Therapeutics employs a patient-focused approach, leveraging strategic intellectual property expansion and AI to de-risk and accelerate its diversified pipeline. These efforts address unmet medical needs in oncology, dermatology, and metabolic disorders, positioning the company as an emerging player in biotechnology. Founded in 2017 and headquartered in New York, New York, Hoth Therapeutics continues to advance its portfolio of novel treatments.

Website

Location

720 Monroe Street

Hoboken, NJ, 07030

United States

Social

What share of all stock conversation is about HOTH?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Attention	0% new	0% new	0% 0	0% 0

May 28

Hoth Therapeutics (now known as Rocket One Inc.) has rebranded to focus on nanomagnetic AI chip technology for space and defense applications.
The company's stock has seen significant price increases, with a 92% gain on May 28, 2026, following the rebrand and ticker change from HOTH to RKTO.
Hoth Therapeutics' business has shifted from its original focus on healthcare and medical research to a new direction in AI computing and semiconductor technologies.

Generated by AI

Sentiment

Of the messages about HOTH that take a side, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Bullish	—	—	—	94.53% +0.71
Bearish	—	—	—	5.47% -0.71

Bullish· May 28

$HOTH has shown significant price appreciation, with a 600% increase, making it a promising investment opportunity.
The company's stock has demonstrated strong momentum, with a 97.8% intraday rise and a subsequent increase in price to $1.36.
The asset's rebranding as $RKTO has been successful, with a 300% increase in value since the announcement, indicating a strong and sustainable trend.

Bearish· May 28

Hoth Therapeutics' market capitalization is too small to compete with trillion-dollar TAM sectors in AI, space, and defense.
The company's focus on radiation-tolerant AI chips, edge AI for satellites, and ultra-low-power computing may not be enough to capture significant market share in these growing sectors.
Hoth Therapeutics is targeting large and growing markets, but its valuation remains at a microcap level, potentially limiting its ability to attract investment and achieve its goals.

Generated by AI

Topics

Of the messages about HOTH that carry a topic, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y
Analysts	—	—	—	1.65%
Announcements	—	—	—	69.09%
Controversies	—	—	—	1.1%
Earnings	—	—	—	0%
Macro	—	—	—	2.88%
Technical Analysis	—	—	—	25.27%

May 27

Hoth Therapeutics, Inc. has rebranded as Rocket One Inc. with a new ticker symbol $RKTO, marking a strategic pivot from biotech to the space economy.
The company has secured exclusive rights to nanomagnetic AI chip technology and ultra-low-power, radiation-tolerant computing for space and defense applications.
Hoth Therapeutics' shares have rallied significantly, with a 92% increase in stock price, following the announcement of its transformation into Rocket One and its entry into the space economy.

Generated by AI

Community

Of the messages about HOTH, what share comes from each group?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Regulars	0%	0%	0%	31.98%
Newcomers	100%	100%	100%	68.02%

Regulars· May 27

The company has completed a name change to Rocket One Inc. and will begin trading as RKTO on the Nasdaq on May 28, 2026, with legacy biotechnology programs continuing under a wholly owned subsidiary.
Rocket One holds exclusive rights to nanomagnetic AI chip technology, targeting the space economy with next-generation nanomagnetic AI chip technology and ultra-low-power, radiation-tolerant computing for space and defense applications.
The stock has seen a massive rally in response to the name change, with some participants expecting a break and base over highs, while others are covering shorts before the change takes effect.

Newcomers· May 28

Many newcomers are celebrating the 600% and 400% gains on $HOTH, with some reporting realized profits of almost 7k.
Some users are questioning the validity of the stock's performance, with one user suggesting it's a scam and another asking where their "HOTH peeps" are.
Newcomers are discussing the company's rebrand to Rocket One Inc. and its focus on orbital computing and defense tech, with one user highlighting the company's new cash runway and warrants overhead.

Generated by AI

Hoth Therapeutics

Social

May 28

Sentiment

Bullish· May 28

Bearish· May 28

Topics

May 27

Community

Regulars· May 27

Newcomers· May 28

Also Discussed

Hoth Therapeutics Inc.

Company Information

Location

Also Discussed

Social

May 28

Sentiment

Bullish· May 28

Bearish· May 28

Topics

May 27

Community

Regulars· May 27

Newcomers· May 28